Literature DB >> 1080129

Independent appearance of anti-thymocyte and anti-RNA antibodies in NZB/NZW F1 mice.

R Goldblum, R Pillarisetty, N Talal.   

Abstract

NZB and NZB/NZW (B/W) mice were studied for natural thymocytoxic autoantibody(NTA) and antibody to reovirus RNA by cytotoxicity and radioimmunoassay respectively.NZB mice developed NTA by 2-3 months of age. RNA antibodies appeared later if atall. NTA and anti-RNA were present in B/W mice starting at 4-5 months and increased in frequency with age. Either activity could appear first and could be present without the other. Thus, all four possible patterns of autoantibody occurrence were found. NTA and anti-RNA in 12-month B/W sera were separable by sucrose density gradient ultracentrifugation; NTA is a 19S IgM antibody whereas anti-RNA is 7S.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080129      PMCID: PMC1445848     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Inability of the NZB-NZW F 1 thymus to transfer cyclophosphamide-induced tolerance to sheep erythrocytes.

Authors:  M E Jacobs; J K Gordon; N Talal
Journal:  J Immunol       Date:  1971-08       Impact factor: 5.422

2.  Depletion of long-lived lymphocytes in old New Zealand black mice.

Authors:  A M Denman; E J Denman
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

Review 3.  Autoimmune and immunoproliferative diseases of NZB/Bl mice and hybrids.

Authors:  R C Mellors
Journal:  Int Rev Exp Pathol       Date:  1966

4.  Filter radioimmunoassay for antibodies to reovirus RNA in systemic lupus erythematosus.

Authors:  M R Attias; R A Sylvester; N Talal
Journal:  Arthritis Rheum       Date:  1973 Nov-Dec

5.  Thymus dependence of cells in peripheral lymphoid tissues and in the circulation sensitive to natural thymocytotoxic autoantibody in NZB mice.

Authors:  T Shirai; T Yoshiki; R C Mellors
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

6.  Cytotoxins in disease. Autocytotoxins in lupus.

Authors:  P I Terasaki; V D Mottironi; E V Barnett
Journal:  N Engl J Med       Date:  1970-10-01       Impact factor: 91.245

7.  DNA-binding assay for detection of anti-DNA antibodies in NZB-NZW F1 mice.

Authors:  A D Steinberg; T Pincus; N Talal
Journal:  J Immunol       Date:  1969-03       Impact factor: 5.422

8.  Incidence of antibodies to double-stranded RNA in systemic lupus erythematosus and related diseases.

Authors:  P H Schur; B D Stollar; A D Steinberg; N Talal
Journal:  Arthritis Rheum       Date:  1971 May-Jun

9.  Strain differences in the immune responses of mice. 3. A raised tolerance threshold in NZB thymus cells.

Authors:  J H Playfair
Journal:  Immunology       Date:  1971-12       Impact factor: 7.397

10.  Natural thymocytotoxic autoantibody and reactive antigen in New Zealand black and other mice.

Authors:  T Shirai; R C Mellors
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

View more
  4 in total

1.  Lymphocytotoxins in epileptic patients receiving phenytoin.

Authors:  B S Ooi; K S Kant; I B Hanenson; A J Pesce; V E Pollak
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

2.  Anti-nucleic acid antibodies in systemic lupus erythematosus patients and their families. Incidence and correlation with lymphocytotoxic antibodies.

Authors:  R J DeHoratius; R Pillarisetty; R P Messner; N Talal
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

3.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

4.  Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE.

Authors:  G M Bahr; G A Rook; E Moreno; P M Lydyard; F Z Modabber; J L Stanford
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.